Odronextamab BLA for Treatment of Relapsed/Refractory Follicular Lymphoma (FL) and Diffuse Large B-cell Lymphoma (DLBCL) Accepted for FDA Priority Review
If approved, odronextamab would be the first and only bispecific antibody approved in both FL…
Social Media
Responsible AI Institute Welcomes Innovative New Members in Q3
AUSTIN, Texas–(BUSINESS WIRE)–Responsible AI Institute (RAI Institute), the non-profit enabling global organizations to harness the…
Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer 2023 Meeting
– Four abstracts highlight Gene Circuit platforms that enhance the scope, precision, effectiveness, and controllability…
Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer 2023 Meeting
– Four abstracts highlight Gene Circuit platforms that enhance the scope, precision, effectiveness, and controllability…
Mithra Announces Presentation of Positive Data on Estetrol (E4) Native Estrogen at NAMS 2023
Independent global leaders in medical research on women’s health, Professor Amanda Black and Professor Wulf…
Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer
NEWS RELEASE September 26, 2023, 5:00PM EDT / 23:00 CET Mdxhealth Signs Research…
Senti Bio to Participate in Upcoming Conferences
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI)…
Modern Health Announces Parenting Expert Emily Oster and Television Personality Karamo As Keynote Speakers At Elevate Conference
Elevate Brings Together Thousands of HR & Benefits Professionals To Discuss The Most Pressing Topics…
Red Cell Partners Launches Savoy Life, a Virtual Healthcare Platform for Long-Term Care
TYSONS, Va.–(BUSINESS WIRE)–Red Cell Partners (Red Cell), an incubation firm building rapidly scalable, technology-led companies…
Biogen Completes Acquisition of Reata Pharmaceuticals
Reata acquisition bolsters Biogen’s rare disease portfolio with the addition of SKYCLARYS® (omaveloxolone), the first…
Biogen Completes Acquisition of Reata Pharmaceuticals
Reata acquisition bolsters Biogen’s rare disease portfolio with the addition of SKYCLARYS® (omaveloxolone), the first…
Lucy Scientific Discovery (NASDAQ: LSDI) Acquisitions Create ‘Golden Opportunity’ for Growth, Success
NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) — NetworkNewsAudio – Lucy Scientific Discovery (NASDAQ: LSDI) announces…
Lucy Scientific Discovery (NASDAQ: LSDI) Acquisitions Create ‘Golden Opportunity’ for Growth, Success
NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) — NetworkNewsAudio – Lucy Scientific Discovery (NASDAQ: LSDI) announces…
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from Phase 2a INTEGRIS-PSC Clinical Trial of Bexotegrast in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
Change in ELF Score at 12 Weeks in INTEGRIS-PSC Change in ELF Score at 12…
Press Release: Dupixent® (dupilumab) sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for FDA Priority Review
Dupixent® (dupilumab) sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11…
Dupixent® (dupilumab) sBLA for Treatment of Eosinophilic Esophagitis (EoE) in Children Aged 1 to 11 Accepted for FDA Priority Review
If approved, Dupixent would be the first and only treatment in the U.S. indicated for…
Sandoz receives European Commission approval for Tyruko® (natalizumab), first and only biosimilar for multiple sclerosis in Europe
Biosimilar Tyruko® approved for all indications of reference medicine, as first and only biosimilar to…
Mithra Financial Results for First-Half 2023
Mithra Financial Results for First-Half 2023 Good progress on strategy to strengthen balance sheet and…
DJI Announces Mini 4 Pro Drone, Upgraded DJI Mini Series; Learn More Info at B&H
DJI upgrades the Miniseries with the release of the Mini 4 Pro drone., the DJI…
Pliant Therapeutics to Host Investor Call and Webcast to Discuss Interim Results from INTEGRIS-PSC, a Phase 2a Trial in Patients with Primary Sclerosing Cholangitis
SOUTH SAN FRANCISCO, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX)…